Busnardo B - Search Results

1

Relationships between metastases of differentiated thyroid carcinoma and serum thyrotropin (TSH) levels.

Busnardo B, Girelli ME, Cimitan M, Casara D, Bui F, Lassi C, Argenti G. Busnardo B, et al. J Clin Endocrinol Metab. 1977 Jun;44(6):1193-6. doi: 10.1210/jcem-44-6-1193. J Clin Endocrinol Metab. 1977. PMID: 874050 No abstract available.

2

TSH levels and TSH response to TRH as a guide to the replacement treatment of patients with thyroid carcinoma.

Busnardo B, Vagelista R, Girelli ME, Bui F, Lazzi C. Busnardo B, et al. J Clin Endocrinol Metab. 1976 May;42(5):901-6. doi: 10.1210/jcem-42-5-901. J Clin Endocrinol Metab. 1976. PMID: 818103

3

Serum thyroglobulin levels in patients with well-differentiated thyroid cancer during suppression therapy: study on 429 patients.

Girelli ME, Busnardo B, Amerio R, Scotton G, Casara D, Betterle C, Piccolo M, Pelizzo MR. Girelli ME, et al. Among authors: busnardo b. Eur J Nucl Med. 1985;10(5-6):252-4. doi: 10.1007/BF00254469. Eur J Nucl Med. 1985. PMID: 3987701

4

Pulmonary metastases from differentiated thyroid carcinoma detected only by radionuclide imaging.

Casara D, Zorat PL, Busnardo B, Girelli ME. Casara D, et al. Among authors: busnardo b. Br J Radiol. 1981 Apr;54(640):362-3. doi: 10.1259/0007-1285-54-640-362. Br J Radiol. 1981. PMID: 7225731 No abstract available.

5

Liver metastases from differentiated thyroid carcinoma.

Casara D, Busnardo B, Cimitan M. Casara D, et al. Among authors: busnardo b. J Nucl Med Allied Sci. 1981 Jan-Jun;25(1-2):53-4. J Nucl Med Allied Sci. 1981. PMID: 7252596 No abstract available.

6

Carcinoembryonic antigen in thyroid cancer.

Cimitan M, Busnardo B, Girelli ME, Casara D, Zanatta GP. Cimitan M, et al. Among authors: busnardo b. J Endocrinol Invest. 1979 Jul-Sep;2(3):241-4. doi: 10.1007/BF03350409. J Endocrinol Invest. 1979. PMID: 528775 No abstract available.

7

Critical evaluation of serum thyroglobulin (Tg) levels during thyroid hormone suppression therapy versus Tg levels after hormone withdrawal and total body scan: results in 291 patients with thyroid cancer.

Girelli ME, Busnardo B, Amerio R, Casara D, Betterle C, Piccolo M. Girelli ME, et al. Among authors: busnardo b. Eur J Nucl Med. 1986;11(9):333-5. doi: 10.1007/BF00253296. Eur J Nucl Med. 1986. PMID: 3082636

8

Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of regular doses of thyroxine and triiodothyronine.

Busnardo B, Bui F, Girelli ME. Busnardo B, et al. J Endocrinol Invest. 1983 Feb;6(1):35-40. doi: 10.1007/BF03350558. J Endocrinol Invest. 1983. PMID: 6341442 No abstract available.

9

Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of an optimal saturation regimen with thyroxine or triiodothyronine.

Busnardo B, Bui F, Girelli ME. Busnardo B, et al. J Endocrinol Invest. 1983 Dec;6(6):455-61. doi: 10.1007/BF03348345. J Endocrinol Invest. 1983. PMID: 6423722

10

Twenty-four hour variations of triiodothyronine (T3) levels in patients who had thyroid ablation for thyroid cancer, receiving T3 as suppressive treatment.

Busnardo B, Girelli ME, Bui F, Zanatta GP, Cimitan M. Busnardo B, et al. J Endocrinol Invest. 1980 Oct-Dec;3(4):353-6. doi: 10.1007/BF03349370. J Endocrinol Invest. 1980. PMID: 6782151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page